0001415889-24-024042.txt : 20240927 0001415889-24-024042.hdr.sgml : 20240927 20240927162018 ACCESSION NUMBER: 0001415889-24-024042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240326 FILED AS OF DATE: 20240927 DATE AS OF CHANGE: 20240927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davidson Michael H. CENTRAL INDEX KEY: 0001573785 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42279 FILM NUMBER: 241335133 MAIL ADDRESS: STREET 1: OMTHERA PHARMACEUTICALS, INC. STREET 2: 707 STATE ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioAge Labs, Inc. CENTRAL INDEX KEY: 0001709941 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474721157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445A SOUTH 50TH STREET CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-806-1445 MAIL ADDRESS: STREET 1: 1445A SOUTH 50TH STREET CITY: RICHMOND STATE: CA ZIP: 94804 4 1 form4-09272024_080914.xml X0508 4 2024-03-26 0001709941 BioAge Labs, Inc. BIOA 0001573785 Davidson Michael H. C/O BIOAGE LABS, INC. 1445A SOUTH 50TH STREET RICHMOND CA 94804 true false false false 0 Stock Option (Right to Buy) 18 2024-09-25 4 A 0 15000 0 A 2034-09-24 Common Stock 15000 15000 D Stock Option (Right to Buy) 8.39 2024-03-26 4 A 0 33986 0 A 2034-03-25 Common Stock 33986 33986 D The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date. This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a). The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on April 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. /s/ Dov A. Goldstein as attorney-in-fact 2024-09-27